期刊文献+

应用动态血糖监测评价甘精胰岛素治疗2型糖尿病患者血糖控制的研究 被引量:50

Using continuous glucose monitoring to evaluate the glycemic control in type 2 diabetes mellitus patients treated with insulin glargine
原文传递
导出
摘要 目的观察应用动态血糖监测(CGM)评价甘精胰岛素治疗的门诊T2DM患者治疗方案调整前后血糖控制情况。方法选取2017年2月至2018年8月于我院内分泌科门诊治疗的T2DM患者105例,随访3个月。随访前后均进行72 h CGM监测,测定血糖、HbA1c、胰岛功能等指标。结果 105例患者基线HbA1c(8.11±1.52)%,HbA1c<7%达标率为24.3%。79例患者完成本研究。治疗方案调整后胰岛素及二甲双胍使用率增加[(21.59±8.36)vs(18.77±5.63)U/d,74.68%vs 53.16%,P<0.05];FBG、HbA1c及C-P120 min/0 min较调整前改善[(8.63±2.62)vs(7.06±1.91)mmol/L,(8.29±1.52)%vs(7.26±1.00)%,(2.52±1.30)vs(3.60±1.67),P<0.05];24 h平均血糖(24 hMBG)、日内血糖平均波动幅度(MAGE)较调整前下降[(10.15±2.59)vs(8.65±1.71)mmol/L,(5.75±2.73)vs(5.04±2.9)mmol/L,P<0.05]。结论甘精胰岛素联合口服药物降糖治疗的T2DM门诊患者整体血糖控制效果欠佳。增加胰岛素剂量及二甲双胍使用率后,患者血糖、餐后胰岛功能反应性、胰岛细胞敏感性及血糖波动均得到改善。 Objective To evaluate the glycemic control of type 2 diabetes mellitus(T2DM)patients treated with insulin glargine before and after the adjustment of treatment by continuous glucose monitoring(CGM).Methods A total of 105 T2DM patients in Endocrinology Clinic of our hospital were recruited and followed up for 3 months.72-hour continuous glucose monitoring(CGM)was applied to all patients,and the blood glucose,HbA1c and islet function were measured at baseline and after follow up for 3 months.Results The average HbA1c was(8.11±1.52)%,with 24.3% reached the target(HbA1c < 7%).A total of 79 patients completed this study.After therapy adjustment,the dosage of insulin and the rate of metformin therapy were increased[(21.59±8.36)vs(18.77±5.63)U/d,74.68% vs 53.16%,P<0.05].FBG,HbA1c and the C-peptide120 min/0 min were improved[(7.06±1.91)vs(8.63±2.62)mmol/L,(7.26±1.00)vs(8.29±1.52)%,(3.60±1.67)vs(2.52±1.30),P<0.05].The 24 hMBG and MAGE were also improved[(8.65±1.71)vs(10.15±2.59)mmol/L,(5.04±2.9)vs(5.75±2.73)mmol/L,P<0.05].Conclusion The glycemic control of T2DM patients treated with insulin glargine and oral hypoglycemic drugs was unsatisfactory in clinic.After increasing the insulin dosage and the usage of metformin,the blood glucose,postprandial islet function responsiveness,islet function and the blood glucose fluctuation were improved.
作者 翟小方 李惠琴 苏晓飞 孔小岑 荆亭 孙小娟 马建华 ZHAI Xiaofang;LI Huiqin;SU Xiaofei(Department of Endocrinology,Nanjing Hospital of Nanjing Medical University,Nanjing 210012,China)
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2020年第4期272-275,共4页 Chinese Journal of Diabetes
基金 国家重点研发计划资助(2018YFC1314100)。
关键词 甘精胰岛素 动态血糖监测 糖尿病 2型 血糖波动 Insulin glargine Continuous glucose monitoring Diabetes mellitus,type 2 Blood glucose fluctuation
  • 相关文献

参考文献4

二级参考文献43

  • 1李霞,周智广,亓海英,陈小燕,黄干.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J].中南大学学报(医学版),2004,29(4):419-423. 被引量:209
  • 2廖勤,梁泽容,屈春梅.两种基础胰岛素类似物——地特胰岛素与甘精胰岛素治疗2型糖尿病临床效果比较[J].实用医院临床杂志,2010,7(4):42-44. 被引量:25
  • 3刘娟,李延兵.早期胰岛素强化治疗在糖尿病治疗中的地位[J].新医学,2006,37(3):144-146. 被引量:34
  • 4中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版).中国糖尿病杂志,2011,20(36):S2-S37.
  • 5Internation Diahetes Federation. The global hurden in:IDF DI- ABETES ATLAS( sixth edition), 2013,29-31.
  • 6Yang WY,Lu JM,Weng JP, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010,362 : 1090-1101.
  • 7Albeni KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classificalion of diabetes mellitus, provisional report of a WHO consultation. Diabet Med, 1998,15 : 539-553.
  • 8Xu Y,Wang LM, He J, et al. Prevalence and Control of Diabe- tes in Chinese Adults. JAMA, 2013,310 : 948-959.
  • 9Bramlage P, Binz C, Gitt AK, et ai. Diabetes treatment patterns and goal achievement in primary diabetes care(DiaRegis)-study protocol and patient characteristics at baseline. Cardiovase Dia betol, 2010,53 : 1-14.
  • 10National Committee for Quality Assurance. Comprehensive diabetes care in:The State of Health Care Quality,2013:51-55.

共引文献185

同被引文献464

引证文献50

二级引证文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部